BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 237 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $20,715,000 | -32.3% | 213,050 | -21.9% | 0.06% | -26.2% |
| Q4 2020 | $30,581,000 | -76.9% | 272,681 | -80.9% | 0.08% | -82.5% |
| Q3 2020 | $132,632,000 | +4.3% | 1,430,767 | -12.2% | 0.48% | -12.8% |
| Q2 2020 | $127,118,000 | +35.8% | 1,629,716 | +1.8% | 0.55% | +12.7% |
| Q1 2020 | $93,595,000 | -10.6% | 1,600,467 | +22.5% | 0.49% | -0.6% |
| Q4 2019 | $104,667,000 | +77.7% | 1,306,541 | +63.0% | 0.49% | +59.6% |
| Q3 2019 | $58,896,000 | +13.3% | 801,639 | +45.5% | 0.31% | +31.8% |
| Q2 2019 | $51,980,000 | -1.4% | 551,040 | -16.3% | 0.23% | -22.8% |
| Q1 2019 | $52,726,000 | -18.5% | 658,661 | -45.1% | 0.30% | -17.9% |
| Q4 2018 | $64,709,000 | +646.2% | 1,200,322 | +980.4% | 0.37% | +666.7% |
| Q3 2018 | $8,672,000 | – | 111,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |